Target intelligence / Profile preview

Neuronal PAS domain-containing protein 3 (NPAS3)

Target
NPAS3
Molecular classification
Transcription factor, Basic helix-loop-helix-PAS (bHLH-PAS) family protein
01

Overview

Neuronal PAS domain-containing protein 3 (NPAS3) is a member of the basic helix-loop-helix-PAS (bHLH-PAS) family of transcription factors, primarily expressed in the nervous system[1][2][3]. NPAS3 forms obligate heterodimers with the aryl hydrocarbon receptor nuclear translocator (ARNT), and together these complexes regulate transcription of specific target genes through direct DNA binding[1][3]. NPAS3 plays an important role in neurodevelopment, adult neurogenesis, and regulation of neural cell proliferation and apoptosis[1][2]. Genetic studies link NPAS3 mutations or altered function to neuropsychiatric conditions such as schizophrenia, autism spectrum disorder, and bipolar disorder[3]. Although its druggability potential is highlighted by the multi-ligand-binding architecture of the bHLH-PAS family, there are currently no known drugs directly targeting NPAS3[3].

Other names
Neuronal PAS domain protein 3BHLHE12MOP6PASD6Neuronal PAS3bHLHe12Basic-helix-loop-helix-PAS protein MOP6Class E basic helix-loop-helix protein 12Member of PAS protein 6PAS domain-containing protein 6
02

Biological functions

Regulation of gene expressionNeurodevelopmentNeurogenesisCell proliferationApoptosis
03

Disease associations

Neurodevelopmental disordersPsychiatric disorders (including schizophrenia, autism spectrum disorders, bipolar disorder)Potential role in neurodegenerative disease
04

Safety considerations

Loss-of-function associated with impaired neurogenesis and altered neural developmentVariants may contribute to neuropsychiatric disorder risk

Beyond the preview

Go deeper on Neuronal PAS domain-containing protein 3 (NPAS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal PAS domain-containing protein 3 (NPAS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call